Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Oral nicotinamide provides robust, dose-dependent structural and metabolic neuroprotection of retinal ganglion cells in experimental glaucoma

Cimaglia, Gloria, Tribble, James R., Votruba, Marcela ORCID: https://orcid.org/0000-0002-7680-9135, Williams, Pete A. and Morgan, James E. ORCID: https://orcid.org/0000-0002-8920-1065 2024. Oral nicotinamide provides robust, dose-dependent structural and metabolic neuroprotection of retinal ganglion cells in experimental glaucoma. Acta Neuropathologica Communications 12 , 137. 10.1186/s40478-024-01850-8

[thumbnail of 40478_2024_Article_1850.pdf] PDF - Published Version
Available under License Creative Commons Attribution.

Download (4MB)

Abstract

A compromised capacity to maintain NAD pools is recognized as a key underlying pathophysiological feature of neurodegenerative diseases. NAD acts as a substrate in major cell functions including mitochondrial homeostasis, cell signalling, axonal transport, axon/Wallerian degeneration, and neuronal energy supply. Dendritic degeneration is an early marker of neuronal stress and precedes cell loss. However, little is known about dendritic structural preservation in pathologic environments and remodelling in mature neurons. Retinal ganglion cell dendritic atrophy is an early pathological feature in animal models of the disease and has been demonstrated in port-mortem human glaucoma samples. Here we report that a nicotinamide (a precursor to NAD through the NAD salvage pathway) enriched diet provides robust retinal ganglion cell dendritic protection and preserves dendritic structure in a rat model of experimental glaucoma. Metabolomic analysis of optic nerve samples from the same animals demonstrates that nicotinamide provides robust metabolic neuroprotection in glaucoma. Advances in our understanding of retinal ganglion cell metabolic profiles shed light on the energetic shift that triggers early neuronal changes in neurodegenerative diseases. As nicotinamide can improve visual function short term in existing glaucoma patients, we hypothesize that a portion of this visual recovery may be due to dendritic preservation in stressed, but not yet fully degenerated, retinal ganglion cells.

Item Type: Article
Date Type: Published Online
Status: Published
Schools: Optometry and Vision Sciences
Additional Information: License information from Publisher: LICENSE 1: URL: http://creativecommons.org/licenses/by/4.0/, Type: open-access
Publisher: BioMed Central
Date of First Compliant Deposit: 27 August 2024
Date of Acceptance: 12 August 2024
Last Modified: 27 Aug 2024 16:30
URI: https://orca.cardiff.ac.uk/id/eprint/171594

Actions (repository staff only)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics